Racial and Ethnic Disparities in Impact of COVID-19

August 06, 2020
Blacks and Latinos are disproportionately affected by COVID-19, according to new data from scientists at 23andMe, illustrating the racial disparities in the impact of the virus.
Read More

23andMe Offers a New Report on APOL1-Related Chronic Kidney Disease

August 05, 2020
23andMe added a new Genetic Health Risk report on APOL1-related chronic kidney disease that has particular relevance for customers with African ancestry.
Read More

23andMe and GSK Begin First Clinical Trial with Cancer Therapy

July 29, 2020
A drug to fight cancer will be the first potential therapy to emerge from 23andMe and GlaxoSmithKline collaboration as the two companies announced that the new therapy will begin clinical trials.
Read More

Introducing L. Okey Onyejekwe Jr.

July 27, 2020
We sit down for a chat with L. Okey Onyejekwe Jr., 23andMe’s new vice president of Consumer Clinical Operations & Medical Affairs.
Read More

23andMe Paper on Transatlantic Slave Trade Published

July 23, 2020
Published today in the American Journal of Human Genetics, a paper by 23andMe scientists using genetic data offers one of the most comprehensive investigations of the transatlantic slave trade ever done.
Read More

A Gift of Knowledge

July 14, 2020
Ann, a genetics professor, used 23andMe to find her mother’s sister. But 23andMe also offered a gift of knowledge with insight into her ancestry and health.
Read More

Researchers Identify New Genetic Associations for Allergies, Asthma and Eczema

July 02, 2020
Using data from the UK Biobank and 23andMe, researchers found new genetic associations for allergies, asthma, and eczema by studying the age of onset.
Read More

23andMe Becomes a Founding Partner For First and Only 24/7 All-News Audio Service Dedicated To The Black Community

June 30, 2020
23andMe joined with seven other companies as a Founding Partner to assist in the launch of iHeartMedia’s BIN: Black Information Network.
Read More

Celebrating Pride Month, a Spotlight on Sex and Gender

June 26, 2020
Pride month is a time to celebrate the love that’s in all our DNA, regardless of someone’s sexual orientation or gender identity. But even though we are all 99.5 percent genetically identical, we still aren’t treated 100 percent equally. 23andme is doing its part to make sure employees and customers are treated equally no matter their sexual orientation or gender identity.
Read More

Improvements to 23andMe’s G6PD Deficiency Report

June 25, 2020
23andMe updated its G6PD Deficiency Genetic Health Risk Report* that now includes the two most common variants linked to G6PD  deficiency, a condition that can lead to episodes of anemia. The update makes this report more comprehensive, and relevant for more people. 
Read More